Log in to save to my catalogue

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and air...

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and air...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ed961ae74dfb4f999b141db01c18adda

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction

About this item

Full title

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction

Publisher

England: BioMed Central Ltd

Journal title

BMC pulmonary medicine, 2024-01, Vol.24 (1), p.49-11, Article 49

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Few studies have reported which inhaled combination therapy, either bronchodilators and/or inhaled corticosteroids (ICSs), is beneficial in patients with bronchiectasis and airflow obstruction. Our study compared the efficacy and safety among different inhaled combination therapies in patients with bronchiectasis and airflow obstruction.
Our ret...

Alternative Titles

Full title

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ed961ae74dfb4f999b141db01c18adda

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ed961ae74dfb4f999b141db01c18adda

Other Identifiers

ISSN

1471-2466

E-ISSN

1471-2466

DOI

10.1186/s12890-024-02867-4

How to access this item